Olaris Therapeutics
Pre-clinicalOlaris uses pioneering metabolomics and machine learning to get the right drug to the right patients at the right time.
Founded
2014
Focus
Diagnostics
About
Olaris uses pioneering metabolomics and machine learning to get the right drug to the right patients at the right time.
Funding History
3Total raised: $42.5M
Series B$30MNorthpond VenturesMar 15, 2022
Series A$10MMPM CapitalJun 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2014
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile